title: Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.
authors.forename: H
authors.initials: H
authors.lastname: Tokgoz
authors.forename: U
authors.initials: U
authors.lastname: Caliskan
authors.forename: G
authors.initials: G
authors.lastname: Lavigne-Lissalde
authors.forename: M
authors.initials: M
authors.lastname: Giansily-Blaizot
mesh_terms: D019774:Blood Coagulation Factor Inhibitors / Q000097:blood; D003029:Coagulants / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005168:Factor VII Deficiency / Q000151:congenital / Q000188:drug therapy* / Q000276:immunology; D015942:Factor VIIa / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D020300:Intracranial Hemorrhages / Q000209:etiology; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage; D012640:Seizures / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D003029:Coagulants; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa